Connect with us

Technology

Analog Devices Reports Fiscal Second Quarter 2025 Financial Results

Published

on

Revenue of $2.64 billion, with double-digit year-over-year growth across all end marketsOperating cash flow of $3.9 billion and free cash flow of $3.3 billion on a trailing twelve-month basis or 39% and 34% of revenue, respectivelyReturned $0.7 billion to shareholders via dividends and repurchases during the second quarter

WILMINGTON, Mass., May 22, 2025 /PRNewswire/ — Analog Devices, Inc. (Nasdaq: ADI), a global semiconductor leader, today announced financial results for its fiscal second quarter 2025, which ended May 3, 2025.

“ADI delivered second quarter revenue and earnings per share above the high end of guidance,” said Vincent Roche, CEO and Chair. “Against a backdrop of global trade volatility, our performance reflects the ongoing cyclical recovery, and the strength and resiliency of our business model. Our unwavering commitment to innovation and customer success, enables ADI to continue extending our leadership at the increasingly AI-driven Intelligent Edge, delivering exceptional value for shareholders over both the near- and long-terms.”

CFO Richard Puccio added, “Second quarter bookings accelerated across all end markets and all regions, resulting in continued sequential backlog growth. The improving demand signals we saw throughout our fiscal Q2, support our outlook for continued growth in Q3, and reinforce our view that we are in a cyclical upturn.”

 Performance for the Second Quarter of Fiscal 2025 

Results Summary(1)

(in millions, except per-share amounts and percentages)

Three Months Ended

May 3, 2025

May 4, 2024

Change

Revenue

$                     2,640

$                       2,159

22 %

Gross margin

$                     1,612

$                       1,180

37 %

Gross margin percentage

61.0 %

54.7 %

630 bps

Operating income

$                        678

$                          386

76 %

Operating margin

25.7 %

17.9 %

780 bps

Diluted earnings per share

$                       1.14

$                         0.61

87 %

Adjusted Results(2)

Adjusted gross margin

$                     1,832

$                       1,440

27 %

Adjusted gross margin percentage

69.4 %

66.7 %

270 bps

Adjusted operating income

$                     1,088

$                          842

29 %

Adjusted operating margin

41.2 %

39.0 %

220 bps

Adjusted diluted earnings per share

$                       1.85

$                         1.40

32 %

Three Months Ended

Trailing Twelve Months

Cash Generation

May 3, 2025

May 3, 2025

Net cash provided by operating activities

$                          819

$                           3,852

% of revenue

31 %

39 %

Capital expenditures

$                           (90)

$                             (559)

Free cash flow(2)

$                          729

$                           3,294

% of revenue

28 %

34 %

Three Months Ended

Trailing Twelve Months

Cash Return

May 3, 2025

May 3, 2025

Dividend paid

$                         (491)

$                          (1,861)

Stock repurchases

(249)

(622)

Total cash returned

$                         (740)

$                          (2,482)

(1) The sum and/or computation of the individual amounts may not equal the total due to rounding.

(2) Reconciliations of non-GAAP financial measures to their most directly comparable GAAP financial measures are provided in the financial tables included in this press release. See also the “Non-GAAP Financial Information” section for additional information.

Outlook for the Third Quarter of Fiscal Year 2025

For the third quarter of fiscal 2025, we are forecasting revenue of $2.75 billion, +/- $100 million. At the midpoint of this revenue outlook, we expect reported operating margin of approximately 27.2%, +/-150 bps, and adjusted operating margin of approximately 41.5%, +/-100 bps. We are planning for reported EPS to be $1.23, +/-$0.10, and adjusted EPS to be $1.92, +/-$0.10.  

Our third quarter fiscal 2025 outlook is based on current expectations and actual results may differ materially as a result of, among other things, the important factors discussed at the end of this release. The statements about our third quarter fiscal 2025 outlook supersede all prior statements regarding our business outlook set forth in prior ADI news releases, and ADI disclaims any obligation to update these forward-looking statements.

The adjusted results and adjusted anticipated results above are financial measures presented on a non-GAAP basis. Reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures are provided in the financial tables included in this release. See also the “Non-GAAP Financial Information” section for additional information.

Dividend Payment

The ADI Board of Directors has declared a quarterly cash dividend of $0.99 per outstanding share of common stock. The dividend will be paid on June 18, 2025 to all shareholders of record at the close of business on June 4, 2025.

Conference Call Scheduled for Today, Thursday, May 22, 2025 at 10:00 am ET

ADI will host a conference call to discuss our second quarter fiscal 2025 results and short-term outlook today, beginning at 10:00 am ET. Investors may join via webcast, accessible at investor.analog.com.

Non-GAAP Financial Information

This release includes non-GAAP financial measures that are not in accordance with, nor an alternative to, U.S. generally accepted accounting principles (GAAP) and may be different from non-GAAP measures presented by other companies. In addition, these non-GAAP measures are not based on any comprehensive set of accounting rules or principles. These non-GAAP measures have material limitations in that they do not reflect all of the amounts associated with the Company’s results of operations as determined in accordance with GAAP and should not be considered in isolation from, or as a substitute for, the Company’s financial results presented in accordance with GAAP. The Company’s use of non-GAAP measures, and the underlying methodology when including or excluding certain items, is not necessarily an indication of the results of operations that may be expected in the future, or that the Company will not, in fact, record such items in future periods. You are cautioned not to place undue reliance on these non-GAAP measures. Reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures are provided in the financial tables included in this release.

Management uses non-GAAP measures internally to evaluate the Company’s operating performance from continuing operations against past periods and to budget and allocate resources in future periods. These non-GAAP measures also assist management in evaluating the Company’s core business and trends across different reporting periods on a consistent basis. Management also uses these non-GAAP measures as primary performance measurements when communicating with analysts and investors regarding the Company’s earnings results and outlook and believes that the presentation of these non-GAAP measures is useful to investors because it provides investors with the operating results that management uses to manage the Company and enables investors and analysts to evaluate the Company’s core business. Management also believes that free cash flow, a non-GAAP liquidity measure, is useful both internally and to investors because it is indicative of the Company’s ability to pay dividends, purchase common stock, make investments and fund acquisitions and, in the absence of refinancings, to repay its debt obligations.  

The non-GAAP financial measures referenced by ADI in this release include: adjusted gross margin, adjusted gross margin percentage, adjusted operating expenses, adjusted operating expenses percentage, adjusted operating income, adjusted operating margin, adjusted nonoperating expense (income), adjusted income before income taxes, adjusted provision for income taxes, adjusted tax rate, adjusted diluted earnings per share (EPS), free cash flow, and free cash flow revenue percentage. 

Adjusted gross margin is defined as gross margin, determined in accordance with GAAP, excluding certain acquisition related expenses1, which are described further below. Adjusted gross margin percentage represents adjusted gross margin divided by revenue. 

Adjusted operating expenses is defined as operating expenses, determined in accordance with GAAP, excluding: certain acquisition related expenses1 and special charges, net2, which are described further below. Adjusted operating expenses percentage represents adjusted operating expenses divided by revenue.

Adjusted operating income is defined as operating income, determined in accordance with GAAP, excluding: acquisition related expenses1 and special charges, net2, which are described further below. Adjusted operating margin represents adjusted operating income divided by revenue. 

Adjusted nonoperating expense (income) is defined as nonoperating expense (income), determined in accordance with GAAP, excluding: certain acquisition related expenses1, which is described further below.   

Adjusted income before income taxes is defined as income before income taxes, determined in accordance with GAAP, excluding: acquisition related expenses1 and special charges, net2, which are described further below.   

Adjusted provision for income taxes is defined as provision for income taxes, determined in accordance with GAAP, excluding tax related items3, which are described further below. Adjusted tax rate represents adjusted provision for income taxes divided by adjusted income before income taxes. 

Adjusted diluted EPS is defined as diluted EPS, determined in accordance with GAAP, excluding: acquisition related expenses1, special charges, net2, and tax related items3, which are described further below.

Free cash flow is defined as net cash provided by operating activities, determined in accordance with GAAP, less additions to property, plant and equipment, net. Free cash flow revenue percentage represents free cash flow divided by revenue.  

1Acquisition Related Expenses: Expenses incurred as a result of current and prior period acquisitions and primarily include expenses associated with the fair value adjustments to debt, property, plant and equipment and amortization of acquisition related intangibles, which include acquired intangibles such as purchased technology and customer relationships. Expenses also include fair value adjustments associated with the replacement of share-based awards related to the Maxim Integrated Products, Inc. (Maxim) acquisition. We excluded these costs from our non-GAAP measures because they relate to specific transactions and are not reflective of our ongoing financial performance.

2Special Charges, Net: Expenses, net, incurred as part of the integration of Maxim, in connection with facility closures, consolidation of manufacturing facilities, severance, other accelerated stock-based compensation expense and other cost reduction efforts or reorganizational initiatives. We excluded these expenses from our non-GAAP measures because apart from ongoing expense savings as a result of such items, these expenses have no direct correlation to the operation of our business in the future.

3Tax Related Items: Income tax effect of the non-GAAP items discussed above. We excluded the income tax effect of these tax related items from our non-GAAP measures because they are not associated with the tax expense on our current operating results.

About Analog Devices, Inc.
Analog Devices, Inc. (NASDAQ: ADI) is a global semiconductor leader that bridges the physical and digital worlds to enable breakthroughs at the Intelligent Edge. ADI combines analog, digital, and software technologies into solutions that help drive advancements in digitized factories, mobility, and digital healthcare, combat climate change, and reliably connect humans and the world. With revenue of more than $9 billion in FY24 and approximately 24,000 people globally, ADI ensures today’s innovators stay Ahead of What’s Possible. Learn more at www.analog.com and on LinkedIn and Twitter (X)

Forward-Looking Statements
This press release contains forward-looking statements, which address a variety of subjects including, for example, our statements regarding future financial performance; impacts related to tariffs and other trade restrictions; economic uncertainty; macroeconomic, geopolitical, demand and other market conditions, business cycles, and supply chains; our hybrid manufacturing strategy; our capital allocation strategy, including future dividends, share repurchases, capital expenditures, investments, and free cash flow returns; expected revenue, operating margin, nonoperating expenses, tax rate, earnings per share, and other financial results; expected market and technology trends and acceleration of those trends; market size, market share gains, market position, and growth opportunities; expected product solutions, offerings, technologies, capabilities, and applications; the value and importance of, and other benefits related to, our product solutions, offerings, and technologies to our customers; and other future events. Statements that are not historical facts, including statements about our beliefs, plans and expectations, are forward-looking statements. Such statements are based on our current expectations and are subject to a number of factors and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in these forward-looking statements: economic, political, legal and regulatory uncertainty or conflict, including increased uncertainty and volatility with respect to tariffs, export controls and other trade restrictions, actions taken or which may be taken by the presidential administration, executive offices of the U.S. government, or U.S. Congress, monetary policy, political, geopolitical, trade, or other issues in the United States or internationally, and the ongoing conflicts between Russia and Ukraine and in Israel and the Middle East; changes in demand for semiconductor products; manufacturing delays, product and raw materials availability and supply chain disruptions; diversion of products from our authorized distribution channels; changes in export classifications, import and export regulations or duties and tariffs; our development of technologies and research and development investments; our future liquidity, capital needs and capital expenditures; our ability to compete successfully in the markets in which we operate; our ability to recruit and retain key personnel; risks related to acquisitions or other strategic transactions; security breaches or other cyber incidents; risks related to the use of artificial intelligence in our business operations, products, and services; adverse results in litigation matters; reputational damage; changes in our estimates of our expected tax rates based on current tax law; risks related to our indebtedness; the discretion of our Board of Directors to declare dividends and our ability to pay dividends in the future; factors impacting our ability to repurchase shares; and uncertainty as to the long-term value of our common stock. For additional information about factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to our filings with the Securities and Exchange Commission, including the risk factors contained in our most recent Annual Report on Form 10-K. Forward-looking statements represent management’s current expectations and are inherently uncertain. Except as required by law, we do not undertake any obligation to update forward-looking statements made by us to reflect subsequent events or circumstances.

Analog Devices and the Analog Devices logo are registered trademarks or trademarks of Analog Devices, Inc. All other trademarks mentioned in this document are the property of their respective owners.

ANALOG DEVICES, INC.

CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(In thousands, except per share amounts)

 

Three Months Ended

Six Months Ended

May 3, 2025

May 4, 2024

May 3, 2025

May 4, 2024

Revenue

$         2,640,068

$         2,159,039

$         5,063,242

$         4,671,743

Cost of sales

1,028,458

979,004

2,021,329

2,017,767

Gross margin

1,611,610

1,180,035

3,041,913

2,653,976

Operating expenses:

   Research and development

441,837

354,862

844,729

746,289

   Selling, marketing, general and administrative

302,669

244,129

587,465

534,207

   Amortization of intangibles

187,415

188,944

374,830

379,276

   Special charges, net

1,745

5,977

65,632

22,117

Total operating expenses

933,666

793,912

1,872,656

1,681,889

Operating income

677,944

386,123

1,169,257

972,087

Nonoperating expense (income):

   Interest expense

74,703

77,103

149,967

154,244

   Interest income

(21,725)

(15,269)

(45,212)

(24,438)

   Other, net

(962)

(314)

2,998

4,260

Total nonoperating expense (income)

52,016

61,520

107,753

134,066

Income before income taxes

625,928

324,603

1,061,504

838,021

Provision for income taxes

56,158

22,361

100,418

73,052

Net income

$            569,770

$            302,242

$            961,086

$            764,969

Shares used to compute earnings per common share – basic

496,173

496,130

496,145

495,947

Shares used to compute earnings per common share – diluted

498,201

498,533

498,434

498,637

Basic earnings per common share

$                   1.15

$                   0.61

$                   1.94

$                   1.54

Diluted earnings per common share

$                   1.14

$                   0.61

$                   1.93

$                   1.53

 

ANALOG DEVICES, INC.

CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and per share amounts)

 

May 3, 2025

Nov. 2, 2024

ASSETS

Current Assets

Cash and cash equivalents

$               2,376,235

$               1,991,342

Short-term investments

371,822

Accounts receivable

1,382,365

1,336,331

Inventories

1,524,897

1,447,687

Prepaid expenses and other current assets

305,040

337,472

Total current assets

5,588,537

5,484,654

Non-current Assets

Net property, plant and equipment

3,336,128

3,415,550

Goodwill

26,945,180

26,909,775

Intangible assets, net

8,787,380

9,585,464

Deferred tax assets

1,985,591

2,083,752

Other assets

701,671

749,082

Total non-current assets

41,755,950

42,743,623

TOTAL ASSETS

$             47,344,487

$             48,228,277

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current Liabilities

Accounts payable

$                  429,405

$                  487,457

Income taxes payable

358,949

447,379

Debt, current

399,636

Commercial paper notes

548,720

547,738

Accrued liabilities

1,353,568

1,106,070

Total current liabilities

2,690,642

2,988,280

Non-current Liabilities

Long-term debt

6,648,417

6,634,313

Deferred income taxes

2,379,575

2,624,392

Income taxes payable

96,354

260,486

Other non-current liabilities

518,879

544,489

Total non-current liabilities

9,643,225

10,063,680

Shareholders’ Equity

Preferred stock, $1.00 par value, 471,934 shares authorized, none outstanding

Common stock, $0.16 2/3 par value, 1,200,000,000 shares authorized, 496,248,196 shares
outstanding (496,296,854 on November 2, 2024)

82,710

82,718

Capital in excess of par value

24,885,204

25,082,243

Retained earnings

10,210,338

10,196,612

Accumulated other comprehensive loss

(167,632)

(185,256)

Total shareholders’ equity

35,010,620

35,176,317

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

$             47,344,487

$             48,228,277

 

ANALOG DEVICES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 

Three Months Ended

Six Months Ended

May 3, 2025

May 4, 2024

May 3, 2025

May 4, 2024

Cash flows from operating activities:

  Net income

$         569,770

$         302,242

$         961,086

$         764,969

  Adjustments to reconcile net income to net cash provided by operations:

       Depreciation

100,334

88,824

198,781

173,172

       Amortization of intangibles

400,273

439,473

817,429

880,376

       Stock-based compensation expense

72,831

58,396

150,405

128,211

       Deferred income taxes

(89,916)

(62,199)

(149,370)

(164,348)

       Other

5,002

8,687

4,203

13,370

       Changes in operating assets and liabilities

(238,816)

(27,570)

(36,247)

150,935

   Total adjustments

249,708

505,611

985,201

1,181,716

Net cash provided by operating activities

819,478

807,853

1,946,287

1,946,685

Cash flows from investing activities:

  Purchases of short-term available-for-sale investments

(424,117)

(424,117)

  Maturities of short-term available-for-sale investments

372,778

372,778

  Additions to property, plant and equipment, net

(90,268)

(188,189)

(239,246)

(411,167)

  Proceeds from sale of property, plant and equipment, net

58,892

58,892

  Payments for acquisitions, net of cash acquired

(45,652)

  Other

(13,209)

10,229

(12,880)

14,106

Net cash provided by (used for) investing activities

328,193

(602,077)

133,892

(821,178)

Cash flows from financing activities:

  Proceeds from debt

1,087,856

1,087,856

  Debt repayments

(399,998)

(399,998)

  Proceeds from commercial paper notes

2,347,064

2,603,907

4,316,340

5,383,401

  Payments of commercial paper notes

(2,346,747)

(2,600,116)

(4,315,358)

(5,382,390)

  Repurchase of common stock

(248,646)

(222,381)

(409,014)

(402,732)

  Dividend payments to shareholders

(491,022)

(456,142)

(947,360)

(882,218)

  Proceeds from employee stock plans

19,815

14,517

61,562

64,336

  Other

(1,896)

2,718

(1,458)

(12,126)

Net cash (used for) provided by financing activities

(1,121,430)

430,359

(1,695,286)

(143,873)

Net increase in cash and cash equivalents

26,241

636,135

384,893

981,634

Cash and cash equivalents at beginning of period

2,349,994

1,303,560

1,991,342

958,061

Cash and cash equivalents at end of period

$     2,376,235

$     1,939,695

$     2,376,235

$     1,939,695

 

ANALOG DEVICES, INC.

REVENUE TRENDS BY END MARKET

(Unaudited)

(In thousands)

 

The categorization of revenue by end market is determined using a variety of data points including the technical characteristics of the product, the “sold to” customer information, the “ship to” customer information and the end customer product or application into which our product will be incorporated. As data systems for capturing and tracking this data and our methodology evolves and improves, the categorization of products by end market can vary over time. When this occurs, we reclassify revenue by end market for prior periods. Such reclassifications typically do not materially change the sizing of, or the underlying trends of results within, each end market.

Three Months Ended

May 3, 2025

May 4, 2024

Revenue

% of Revenue1

Y/Y%

Revenue

% of Revenue1

Industrial

$        1,157,747

44 %

17 %

$           991,446

46 %

Automotive

849,505

32 %

24 %

684,102

32 %

Consumer

317,756

12 %

30 %

244,947

11 %

Communications

315,060

12 %

32 %

238,544

11 %

Total revenue

$        2,640,068

100 %

22 %

$        2,159,039

100 %

Six Months Ended

May 3, 2025

May 4, 2024

Revenue

%  of Revenue1

Y/Y%

Revenue

% of Revenue1

Industrial

$        2,229,837

44 %

2 %

$        2,181,828

47 %

Automotive

1,584,534

31 %

11 %

1,433,586

31 %

Consumer

634,667

13 %

23 %

514,063

11 %

Communications

614,204

12 %

13 %

542,266

12 %

Total revenue

$        5,063,242

100 %

8 %

$        4,671,743

100 %

1) The sum of the individual percentages may not equal the total due to rounding.

 

ANALOG DEVICES, INC.

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

(Unaudited)

(In thousands, except per share amounts)

 

Three Months Ended

Six Months Ended

May 3, 2025

May 4, 2024

May 3, 2025

May 4, 2024

Gross margin

$         1,611,610

$         1,180,035

$         3,041,913

$         2,653,976

  Gross margin percentage

61.0 %

54.7 %

60.1 %

56.8 %

      Acquisition related expenses

220,277

259,641

458,109

519,525

Adjusted gross margin

$         1,831,887

$         1,439,676

$         3,500,022

$         3,173,501

  Adjusted gross margin percentage

69.4 %

66.7 %

69.1 %

67.9 %

Operating expenses

$            933,666

$            793,912

$         1,872,656

$         1,681,889

  Percent of revenue

35.4 %

36.8 %

37.0 %

36.0 %

      Acquisition related expenses

(188,015)

(190,200)

(376,030)

(382,622)

      Special charges, net

(1,745)

(5,977)

(65,632)

(22,117)

Adjusted operating expenses

$            743,906

$            597,735

$         1,430,994

$         1,277,150

  Adjusted operating expenses percentage

28.2 %

27.7 %

28.3 %

27.3 %

Operating income

$            677,944

$            386,123

$         1,169,257

$            972,087

  Operating margin

25.7 %

17.9 %

23.1 %

20.8 %

      Acquisition related expenses

408,292

449,841

834,139

902,147

      Special charges, net

1,745

5,977

65,632

22,117

Adjusted operating income

$         1,087,981

$            841,941

$         2,069,028

$         1,896,351

  Adjusted operating margin

41.2 %

39.0 %

40.9 %

40.6 %

Nonoperating expense (income)

$              52,016

$              61,520

$            107,753

$            134,066

      Acquisition related expenses

2,150

2,150

4,300

4,300

Adjusted nonoperating expense (income)

$              54,166

$              63,670

$            112,053

$            138,366

Income before income taxes

$            625,928

$            324,603

$         1,061,504

$            838,021

     Acquisition related expenses

406,142

447,691

829,839

897,847

     Special charges, net

1,745

5,977

65,632

22,117

Adjusted income before income taxes

$         1,033,815

$            778,271

$         1,956,975

$         1,757,985

Provision for income taxes

$              56,158

$              22,361

$            100,418

$              73,052

Effective income tax rate

9.0 %

6.9 %

9.5 %

8.7 %

     Tax related items

57,573

59,929

122,635

124,959

Adjusted provision for income taxes

$            113,731

$              82,290

$            223,053

$            198,011

Adjusted tax rate

11.0 %

10.6 %

11.4 %

11.3 %

Diluted EPS

$                  1.14

$                  0.61

$                  1.93

$                  1.53

      Acquisition related expenses

0.82

0.90

1.66

1.80

      Special charges, net

0.01

0.13

0.04

      Tax related items

(0.12)

(0.12)

(0.25)

(0.25)

Adjusted diluted EPS*

$                  1.85

$                  1.40

$                  3.48

$                  3.13

* The sum of the individual per share amounts may not equal the total due to rounding.

 

ANALOG DEVICES, INC.

RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO FREE CASH FLOW

(Unaudited)

(In thousands)

 

Trailing
Twelve
Months

Three Months Ended

May 3, 2025

May 3, 2025

Feb. 1, 2025

Nov. 2, 2024

Aug. 3, 2024

Revenue

$  9,818,656

$  2,640,068

$  2,423,174

$  2,443,205

$  2,312,209

Net cash provided by operating activities

$  3,852,131

$     819,478

$  1,126,809

$  1,050,817

$     855,027

% of Revenue

39 %

31 %

47 %

43 %

37 %

Capital expenditures

$    (558,542)

$      (90,268)

$    (148,978)

$    (165,410)

$    (153,886)

Free cash flow

$  3,293,589

$     729,210

$     977,831

$     885,407

$     701,141

% of Revenue

34 %

28 %

40 %

36 %

30 %

 

ANALOG DEVICES, INC.

RECONCILIATION OF PROJECTED GAAP TO NON-GAAP RESULTS

(Unaudited)

 

Three Months Ending August 2, 2025

Reported

Adjusted

Revenue

$2.75 Billion

$2.75 Billion

(+/- $100 Million)

(+/- $100 Million)

Operating margin

27.2 %

41.5 %(1)

(+/-150 bps)

(+/-100 bps)

Nonoperating expenses

~ $55 Million

~ $55 Million

Tax rate

11% – 13%

11% – 13% (2)

Earnings per share

$1.23

$1.92 (3)

(+/- $0.10)

(+/- $0.10)

(1)

Includes $391 million of adjustments related to acquisition related expenses as previously defined in the Non-GAAP Financial Information section of this press release. 

(2)

Includes $51 million of tax effects associated with the adjustment for acquisition related expenses noted above.

(3)

Includes $0.69 of adjustments related to the net impact of acquisition related expenses and the tax effects on those items.

For more information, please contact:

Jeff Ambrosi
781-461-3282
Senior Director, Investor Relations
investor.relations@analog.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/analog-devices-reports-fiscal-second-quarter-2025-financial-results-302462613.html

SOURCE Analog Devices, Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

BillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagnostics

Published

on

By

A breakthrough in prenatal care, Unity Confirm enables non-invasive confirmation for high-risk screening results through the capture of intact circulating fetal cells using BillionToOne’s Fetal Cell Capture™ Technology

MENLO PARK, Calif., May 1, 2026 /PRNewswire/ — For more than two decades, the ultimate quest for scientists and clinicians studying prenatal genetics was the capture of an intact fetal cell non-invasively so that its fetal DNA could be directly analyzed. While cell-free DNA has revolutionized prenatal genetics, it left an uncertainty—a gap between screening and invasive diagnostics, for patients who cannot, or choose not to, access invasive diagnostics. Today, BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announced the launch of Unity Confirm™, a circulating fetal cell-based, non-invasive confirmation test, designed to address this need from a simple maternal blood draw.

Since its introduction in the early 2010s, non-invasive prenatal testing (NIPT) has become the standard of care for screening for fetal aneuploidies. However, when screening returns a high-risk result, clinical guidelines recommend diagnostic confirmation via chorionic villus sampling (CVS) or amniocentesis. These invasive procedures carry a small but real risk of pregnancy loss, and are increasingly difficult to access. The majority of patients decline, leaving clinicians and families without the information needed to guide next steps, and widening gaps in inequitable care.

While cell-based prenatal genetics has been studied since before the advent of cell-free DNA tests, the scientific barrier has long been the rarity and fragility of fetal cells in maternal circulation. Presenting at fewer than one cell per milliliter of blood and nearly indistinguishable from millions of surrounding maternal cells, intact circulating fetal cells have been too difficult to isolate in an accessible way for clinical use. The cell-based approaches were previously studied across multiple independent publications1 in more than 1,500 patients, consistently demonstrating that when a fetal cell is captured and sequenced, it provides an accurate result that has extremely high concordance with invasive diagnostic testing. However, these methodologies have stayed too academic, expensive, and inaccessible.

Unity Confirm addresses this directly. Available for all patients who use UNITY Aneuploidy for their front-line screen*, BillionToOne’s Fetal Cell Capture™ technology, a multi-step immunological enrichment and single cell isolation process, isolates intact circulating fetal cells, effectively providing 100% fetal fraction2, and performs whole genome sequencing on each individual cell. By analyzing the direct fetal cells rather than fragmentary cfDNA, similar to invasive procedures, Unity Confirm delivers rapid CVS-like insights3 non-invasively, from a single blood draw.

“For years, the idea of capturing whole fetal cells non-invasively was largely viewed as an elusive holy grail, something theoretically possible but practically out of reach,” said Oguzhan Atay, PhD, Co-founder and CEO of BillionToOne. “Unity Confirm is proof that it does not have to be. For the first time, a clinician can confirm a high-risk prenatal result non-invasively, with a level of accuracy the field has never before seen outside of an invasive procedure. For the first time, this technology is broadly accessible.”

“A high-risk NIPT result does not give you a diagnosis. It gives you a decision to make under enormous stress, often without enough information,” said Haywood Brown, MD, Chief Medical Officer, Prenatal, BillionToOne. “For too long, the options were limited: forgo confirmation, or undergo an invasive procedure with a small but real risk. What makes Unity Confirm truly different is not just the science; it is that this capability is now clinically accessible. That’s not an incremental improvement. That is a fundamentally different standard of care.”

In BillionToOne’s own clinical validation, Unity Confirm demonstrated 100% concordance with known fetal outcomes and invasive diagnostic results across 16 of 16 samples, including affected fetuses for common aneuploidies and 22q11.2 microdeletion. The clinical data supporting Unity Confirm will be presented at ACOG 2026 in Washington, D.C., presenting the science behind the technology to the broader OB/GYN community for the first time. Beginning on May 28, providers using Unity Aneuploidy™ Screen will have access to Unity Confirm following a high-risk result. To further validate performance at scale, BillionToOne is now enrolling in the largest prospective study of a fetal cell-based confirmation assay with invasive diagnostic outcomes, targeting enrollment of 1,000 patients and measuring concordance to invasive diagnostic testing.

*Unity Confirm is intended for patients who cannot, or choose not to, pursue invasive diagnostic testing following a high-risk Unity Aneuploidy Screen result before 16 weeks of gestation. Available for Trisomy 21 (Down syndrome), Trisomy 18, Trisomy 13, 22q11.2 microdeletion, XXY, XYY, and XXX aneuploidies. Requires Unity Aneuploidy Screen as the frontline screen for the pregnancy.

Sources

1Hatt, Lotte, et al. “A new marker set that identifies fetal cells in maternal circulation with high specificity.” Prenatal Diagnosis 34.11 (2014): 1066-1072.; Stampalija, T., et al. “Single-cell-based non-invasive screening for fetal pathogenic microimbalances using maternal blood: comparison with invasive prenatal diagnosis.” Ultrasound in Obstetrics & Gynecology (2026).; Weymaere, Jana, et al. “Enrichment of circulating trophoblasts from maternal blood using filtration-based Metacell® technology.” Plos one 17.7 (2022):e0271226.; Jeppesen, Line Dahl, et al. “Screening for Fetal Aneuploidy and Sex Chromosomal Anomalies in a Pregnant Woman with Mosaicism for Turner Syndrome—Applications and Advantages of Cell-Based NIPT.” Frontiers in Genetics 12 (2021): 741752.; Bellair, Michelle, et al. “Noninvasive single-cell-based prenatal genetic testing: A proof of concept clinical study.” Prenatal Diagnosis 44.3 (2024):304-316.; Chakchouk, Imen, and Ignatia B. Van den Veyver. “Whole-Genome Amplification on Single Circulating Trophoblast Cell.” Whole Genome Amplification: Methods and Protocols. New York, NY: Springer US, 2026. 11-23.; Zhuo, Xinming, et al. “Use of amplicon-based sequencing for testing fetal identity and monogenic traits with Single Circulating Trophoblast (SCT) as one form of cell-based NIPT.” PLoSOne 16.4 (2021): e0249695.

2In rare instances, results may rely on a single cell that is co-sequenced with 1-2 maternal cells, which may reduce fetal fraction to 50% or 33%. When this occurs, the report clearly indicates this limitation.

3Unity Confirm and rapid CVS both analyze fetal-derived trophoblast cells. Unity Confirm isolates individual cells via whole genome sequencing (WGS), which is performed on each cell separately, whereas rapid CVS is often performed via FISH. While rapid CVS may analyze more cells, WGS generates more data per cell. In both rapid CVS and fetal cell capture, mosaicism cannot be excluded. Unity Confirm may have false-positive and false-negative results. Results are not a guaranty. Important medical decisions should not rely on UnityConfirm test results alone. Clinical correlation is necessary. Unity Confirm is a laboratory-developed test performed in a CLIA-certified and CAP-accredited laboratory. It is not an FDA-approved or FDA-cleared diagnostic test. Test performance may vary based on gestational age and other factors.

Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of federal securities laws. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward-looking statements in this press release include, but are not limited to, statements regarding the clinical effectiveness of Unity Confirm. These statements are based on management’s current expectations, forecasts and assumptions, and actual outcomes and results could differ materially from these statements due to a number of factors, some of which are beyond BillionToOne’s control. These and additional risks and uncertainties could affect BillionToOne’s financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. These risks and uncertainties include, but are not limited to, the risk that Unity Confirm is not clinically effective and not  adopted by healthcare professionals and those discussed under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operation” and elsewhere in BillionToOne’s most recently filed Annual Report on Form 10-K, and other filings we make with the Securities and Exchange Commission from time to time. The forward-looking statements in this press release are based on information available to BillionToOne as of the date hereof, and BillionToOne disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing BillionToOne’s views as of any date subsequent to the date of this press release.

About BillionToOne
Headquartered in Menlo Park, California, BillionToOne is a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company’s patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level. For more information, visit www.billiontoone.com.

Media Contact
billiontoone@moxiegrouppr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/billiontoone-launches-unity-confirm-a-category-defining-test-that-bridges-the-gap-between-screening-and-invasive-diagnostics-302760412.html

SOURCE BillionToOne

Continue Reading

Technology

2026 Brockton High School Film Festival

Published

on

By

Brockton High School Students Premiere Original Films Exploring Mental Wellness and Leadership

Twenty-three student creators showcase cinematic takes on boundaries, bias, and leadership; selected works to advance to the National SALT 12 Film Festival.

BROCKTON, Mass., May 1, 2026 /PRNewswire-HISPANIC PR WIRE/ — Brockton High School hosted the 2026 Brockton High School Film Festival, a community celebration of student voice and mental wellness. Organized by the nonprofit SALT ED Inc., the event premiered five original short films created by 23 students participating in the “Reel Funny” program.

Unlike traditional film programs, Reel Funny uses media production as a vehicle for personal growth rather than just technical instruction. The program guides students through a series of workshops focused on “soft skills”—including conflict resolution, recognizing internal bias, and establishing healthy personal boundaries. Students are then challenged to apply these lessons by collaborating in groups to write, produce, and edit their own films entirely independently.

A unique and critical component of the Reel Funny process is its integration of mental health professional oversight. Following the students’ film submissions, Eun Joo You, a Licensed Clinical Social Worker (LCSW) with Care Plus New Jersey, conducted a specialized screening of the works. This clinical review serves to evaluate student mental wellness and identify early signs of emotional distress, followed by direct engagement with the students to discuss their creative themes and overall well-being.

“The opportunity for our students to engage in this type of work is paramount to their development as well-rounded individuals,” said Kevin McCaskill, Principal of Brockton High School. “When we talk about preparing the next generation of leaders, we aren’t just talking about academics; we are talking about the emotional intelligence and self-awareness that programs like ‘Reel Funny’ provide. These films are a powerful reflection of their growth.”

The celebration invited friends, families, and local community members to acknowledge the leadership and vulnerability displayed by these young creators.

“This program empowers students to turn self-reflection into a leadership tool,” said Joonho Lee, CEO of Kbean®, a primary supporter of the initiative. “By giving students the autonomy to produce these films on their own terms, we see a level of authenticity that traditional education often misses.”

Looking Ahead: The SALT 12 National Showcase 
The Brockton High School festival serves as a qualifying event for the 3rd Annual SALT 12 Film Festival scheduled for the end of 2026. SALT 12 is a national platform that gathers the most impactful student films from across the country, allowing participants to share their voices with a public audience and compete for national recognition.

For more information about SALT ED Inc., the Reel Funny curriculum, or the upcoming SALT 12 National Showcase, please visit www.salt-ed.org.

About SALT ED Inc.
SALT ED Inc. is a nonprofit organization dedicated to empowering underserved youth through media production, workforce development, and mental wellness initiatives. Their signature “Reel Funny” program helps students develop the emotional intelligence and leadership skills necessary to succeed as next-generation leaders.

Photo – https://mma.prnewswire.com/media/2954869/Picture1.jpg

Logo – https://mma.prnewswire.com/media/1897111/5888831/Kbean_Logo.jpg

SOURCE Kbean

Continue Reading

Technology

Products That Count Announces the Winners of the 2026 CPO Awards, Honoring the Product Leaders Redefining Their Craft in the AI Era

Published

on

By

The annual Awards recognize Chief Product Officers whose scope, influence, and impact have expanded dramatically as AI reshapes every organization.

SAN FRANCISCO, May 1, 2026 /PRNewswire-PRWeb/ — Products That Count, the world’s largest nonprofit community of product managers with over 600,000 members, today announced the winners of the 2026 CPO Awards. The Awards, produced in partnership with Mighty Capital, celebrate the Chief Product Officers whose leadership is shaping how products are built, shipped, and scaled in a moment of unprecedented change.

“The CPO mandate has fundamentally expanded,” said SC Moatti, Founder and Managing Partner of Products That Count. “Our winners this year are setting the standard for what the role becomes when AI is woven into every layer of the business. They are the builders other builders learn from.”

The role of the Chief Product Officer has never been broader. Today’s CPOs are architecting the systems, teams, and decisions that determine whether their companies win in the AI era.

The 2026 CPO Award Winners, by category:

President / CEO: Former CPOs who have elevated to the top role.

Eglae Recchia, CPO, Keyway

Maria Thomas, CEO (promoted from CPO), Rebrandly

Nabil Bukhari, President, Extreme Networks

Shiven Ramji, President & Chief Product Officer, Okta

Investor Mindset: Treating product like a portfolio of bets, with M&A as a strategic lever.

Achuth Rao, CPO, New York Life Insurance Company

Andrew Tsao, CPO & Analytics Officer, Audible

Dane Glasgow, CPO, Paramount/Skydance

Diana Benli, Chief Product Officer, Cognizant

Diego Dugatkin, Chief Product Officer, Box

Mike Bidgoli, CPO & CTO, Tubi

Vasu Murthy, CPO, Cohesity

Vrushali Paunikar, CPO, Carta

Ambrish Verma, Chief Product Officer, Ingram Micro

Enterprise Scale: Operating in complexity. Not speed alone, but transformation at scale.

Carla Guzzetti, Chief Product Officer, Cloud Applications, Extreme Networks

Eddie Garcia, Chief Product Officer, eBay

Gautam Shah, Chief Product Officer, Carelon

Ghazal Badiozamani, SVP of Product Management, Cengage

Kelli Fielding, Chief Product Officer, Europe, TransUnion

Mikhail Vaysbukh, Chief Product Officer, Elsevier

Monica Ugwi, GM, Copilot + Agents for Manufacturing & Mobility, formerly Microsoft

Randall Hounsell, SVP Connected Living Product, Comcast

Rita Khan, Chief Consumer & Digital Officer, formerly Optum

Ryan Bergstrom, Chief Product Officer, Paychex

Tim Simmons, Chief Product Officer, formerly Walmart International

Tina Tarquinio, Chief Product Officer, IBM Z and LinuxONE, IBM

Todd Garner, CPO, Sam’s Club

Trey Courtney, Global Chief Product & Partnerships Officer, Mood Media

Wyatt Jenkins, SVP Product, Intuit

Shayani Roy, SVP Product Management and Design, OpenTable

Scale Up: Growth-stage leaders putting the scale in place.

Aaron Seevers, Chief Product Officer, Noom

Avijit Sinha, SVP Corporate Development, EDB

Hannah Park, Chief Product Officer, Planned Parenthood

Joe Futty, CPO & CTO, Pipedrive

Jonathan Shottan, Chief Product Officer, Tonal

Kimberly Bloomston, CPO, 6sense

Kousthub Raghavan, Chief Product & Digital Officer, CLEAR

Natalia Williams, Chief Product Officer, Qonto

Nikita Miller, Chief Product Officer, Perk

Nilesh Khandelwal, Chief Product Officer, Rakuten Rewards

Paul Burke, CPO, Reveleer

Randhir Vieira, CPO, formerly Healthify

Renn Turiano, CPO, Gannett – USA Today Network

Sarah Turrin, CPO, Color

Emerging: On an amazing trajectory, regardless of tenure.

Adam Kelsey, EVP, Product Management, SignalWire

Apurva Garware, SVP, Head of Product, Invisible Technologies

Chai Atreya, Chief Product Officer, ActiveCampaign

Jack Brody, Chief Product Officer, Suno

John Barrus, VP of Product Management, Niobium

Kevin Swint, former Co-Founder & CPO, RemixAI

Nirmal Kumar, CPO, Aliaswire

Rafael Flores, Chief Product Officer, Treasure Data.ai

Sarah Jacob Singh, CPO & CTO, Medbridge

Sarosh Waghmar, CPO & Co-Founder, Spotnana

Vanessa Davis, CPO, LegalOn

Vikas Seth, CPO, ARIS

Platform: Multiplying impact beyond their own product by leveraging the ecosystem at scale.

Arnab Bose, CPO, Asana

Kishan Chetan, EVP & GM, Agentforce Service Cloud, Salesforce

Shardul Vikram, Chief Product Officer, SAP Application AI, SAP

Tom Occhino, Chief Product Officer, Vercel

Rohit Badlaney, CPO & General Manager, IBM Cloud Platform, IBM

Terre Layton, former CPO, BetterHealth

B.J. Boyle, Chief Product Officer, MacroHealth

Winners were selected by an Independent Advisory Council of seasoned product executives based on impact and leadership.

ABOUT PRODUCTS THAT COUNT

Products That Count is the world’s largest nonprofit community, engaging 600,000+ product managers and Chief Product Officers (CPOs) united by a mission: to empower everyone to build products that truly count. In a world flooded with products, only a few ignite passion, deliver value at scale, and transform lives. Behind those exceptional products are visionary CPOs and high-performing product teams driving innovation at the most bleeding-edge companies. We recognize these trailblazers through our coveted Awards, accelerate careers from PM to the C-suite and beyond through daily best practices, and serve as the trusted advisor to nearly all Fortune 1000 CPOs. Our Corporate Alliance includes Walmart, Ford, Cisco, Johnson & Johnson, Amplitude, and more. The most admired product leaders across industries serve on our Advisory Council, guiding the future of product leadership. Together, we’re shaping a future where every product counts. Learn more at productsthatcount.org

ABOUT MIGHTY CAPITAL

Mighty Capital is the VC firm that leverages the Product Alpha Effect, a data-backed framework for outperformance that proves great products drive great businesses. Founded in 2018 by SC Moatti, a product visionary and former Meta product leader, and Jennifer Vancini, a veteran of tech investing and M&A, we bring a differentiated edge to venture. Through Moatti’s 600,000-strong Products That Count network of product leaders, we see where the world is going before others do. That proprietary signal gives us an advantage in sourcing, diligence, and post-investment value creation. Our portfolio speaks for itself: 1 in 5 companies is a category leader like Amplitude (NASDAQ:AMPL), Groq, and Netskope (NASDAQ:NTSK). Founders consistently call us the most value-add investor on their cap table, and use our global product ecosystem as a marketplace to accelerate time to revenue, scale, and exit. Anchored by GCM Grosvenor, we’re deploying Fund III with both prior funds in top decile DPI and TVPI, more than $20B in value created, and 6 IPOs to date. Learn more at Mighty.Capital.

Media Contact

Emma Shirlin, Products That Count, 1 8287020154, emmashirlin@productsthatcount.com

View original content:https://www.prweb.com/releases/products-that-count-announces-the-winners-of-the-2026-cpo-awards-honoring-the-product-leaders-redefining-their-craft-in-the-ai-era-302759934.html

SOURCE Products That Count

Continue Reading

Trending